Navigation Links
Pediatric HIV/AIDS Experts to Present at 2013 International AIDS Society Conference
Date:6/24/2013

Washington, D.C. (PRWEB) June 24, 2013

WHAT: International AIDS Society (IAS) 2013: The 7th IAS Conference on HIV Pathogenesis, Treatment, and Prevention

Experts from the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) will give oral presentations, moderate conference events, and exhibit a variety of educational posters and abstracts. They will also be available for media questions and public comments on any breaking news and research presented at the conference related to:

  •     Pediatric HIV/AIDS treatments
  •     Prevention of mother-to-child transmission (PMTCT)
  •     New World Health Organization (WHO) guidelines related to Option B+
  •     New WHO treatment guidelines for children younger than 5 years of age
  •     Maternal and child health
  •     Health system strengthening

Daily updates and a full list of presentations and poster session featuring EGPAF staff is available here: http://www.pedaids.org/Press-Room/Events/2013/7th-IAS-Conference-on-HIV-Pathogenesis,-Treatment-

WHEN: June 30–July 3, 2013

WHERE: Kuala Lumpur Convention Centre (KLCC)
Jalan Ampang
50088 Kuala Lumpur
Federal Territory of Kuala Lumpur
Malaysia

WHO: Experts from the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF):

  •     Laura Guay, M.D., Vice President of Research
  •     R.J. Simonds, M.D., Vice President of Program Innovation and Policy
  •     Appolinaire Tiam, Acting Country Director, Lesotho

WHY: Held every two years, the conference attracts approximately 5,000 delegates from all over the world. It is a unique opportunity for the world’s leading scientists, clinicians, public health experts, and community leaders to examine the latest developments in HIV-related research, and to explore how scientific advances can – in very practical ways – inform the global response to HIV/AIDS.

EGPAF experts will be able to offer perspectives on these new developments and other breaking news items as they related to efforts to eliminate pediatric HIV/AIDS infections worldwide.

CONTACT: To schedule an interview in-person or via phone with the experts list above, please contact Johanna Harvey, EGPAF Senior Communications Officer at +1 (202) 280-1657 or jharvey(at)pedaids(dot)org or Jane Coaston, Media Relations Coordinator at +1 (202) 280-1648 or jcoaston(at)pedaids(dot)org.

About the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF):
EGPAF is a global leader in the fight against pediatric HIV/AIDS, and has reached more than 16 million women with services to prevent transmission of HIV to their babies. It currently works at more than 5,500 sites and in 15 countries to implement prevention, care, and treatment services; to further advance innovative research; and to execute global advocacy activities that bring dramatic change to the lives of millions of women, children, and families worldwide. For more information, visit http://www.pedaids.org.

Read the full story at http://www.prweb.com/releases/2013/6/prweb10863092.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Anderson Pediatric Dentistry PA Welcomes New Team Member
2. Nemours Pediatric ENT Performs Minimally Invasive Procedure on South Florida Boy at Wolfson Children’s Hospital in Jacksonville, FL
3. One Million Babies Born HIV-free Signals Major Milestone in Global Effort to Eliminate Pediatric AIDS
4. Multidisciplinary initiative reduces airway infection in pediatric intensive care patients
5. Nationwide Children’s Hospital Develops First Pediatric-Focused Diabetes Calculator
6. Mayo Clinic first in US to test stem cells in pediatric congenital heart disease patients
7. Reducing Unnecessary and High-dose Pediatric CT Scans Could Cut Associated Cancers by 62 Percent
8. When Tragedies Impact Children – Kentucky Emergency Medical Services for Children (KYEMSC) Offers Specialized Training for Pediatric Emergency Care
9. Early removal of adenoids and tonsils can help pediatric sleep apnea symptoms
10. Exposure to Secondhand Smoke May Lead to Worsening of Pediatric Kidney Disease; Pediatric Nephrology Publishes Dayton Children’s, Johns Hopkins Joint Study
11. Most Michigan parents, grandparents prefer research hospitals for pediatric care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... In 1987, McDaniel & ... years in business this year, and they’re marking the milestone by undertaking a ... their patients. , It stands to reason that, given the central importance ...
(Date:8/16/2017)... ... August 16, 2017 , ... ... has received a three-year grant totaling $975,000, renewing its funding from the Health ... Human Services. , This funding marks, the fourth time the HRSA administration has ...
(Date:8/16/2017)... ... August 16, 2017 , ... SGNA Standards ... after every reprocessing cycle, both between patient procedures and before storage, is a ... is as important to the prevention of disease transmission and nosocomial infection as ...
(Date:8/16/2017)... ... August 16, 2017 , ... Connexion Point, a technology-enabled ... list for the fourth consecutive year. With 197% revenue growth over the ... the nation’s fastest growing companies. , Previous honors include ranking 86th on ...
(Date:8/16/2017)... TX (PRWEB) , ... August 16, 2017 , ... ... the United States, named Dr. Douglas J. Harrison, as the new Medical Director of ... be the new facility Medical Director of our Sienna Plantation location,” said Dr. Michael ...
Breaking Medicine News(10 mins):
(Date:7/31/2017)... Tenn. , July 31, 2017 Three Tru-D SmartUVC ... Yongsan, South Korea . Tru-D, short for "Total Room ... and operating rooms after an environmental services (ES) professional cleans the area ... ... "Although the ...
(Date:7/27/2017)... EXTON, Pa., July 27, 2017  West Pharmaceutical Services, ... financial results for the second-quarter 2017 and updated financial ... Second-Quarter 2017 Highlights Reported ... 2.5% over the prior-year quarter. Net sales at constant ... 2017 reported-diluted EPS was $0.51, compared to $0.60 in ...
(Date:7/25/2017)... BARCELONA, Spain and CAMBRIDGE, Massachusetts ... SOM Biotech, specializing in repurposing drugs to treat rare nervous ... Therapeutics Inc. to clinically develop and market the drug SOM0226 ... reached, the drug achieved very promising results in a Phase ... A new office in the United ...
Breaking Medicine Technology: